Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Jun;84(3):501–507.

Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.

I Bourgault 1, A Gomez 1, E Gomard 1, J P Levy 1
PMCID: PMC1535418  PMID: 1646086

Abstract

Human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) play an important role in maintaining the virus/host equilibrium during persistent infections. We analysed precursors of anti-EBV CTL by the limiting-dilution technique. Seven healthy EBV-seropositive and two EBV-seronegative donors were tested. All the donors seropositive for EBV gave clear-cut positive results, and it was remarkable that the frequency of CTL precursors (CTLp) observed was much higher than that reported for other viruses. In contrast, in the seronegative donors the frequency of CTLp was undetectable. The CTLp were derived from the CD4-CD8+ population only, although EBV-specific CD4+ cytolytic T cell clones have been described. A study of the HLA restriction showed that some HLA-A or HLA-B antigens can function as preferential restricting molecules, but that CTLp restricted by the other HLA-A or HLA-B molecules also exist. However, the dominant population of CTL present in primary responses is sometimes different from that of long term cell lines established from the same donor.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borysiewicz L. K., Graham S., Hickling J. K., Mason P. D., Sissons J. G. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur J Immunol. 1988 Feb;18(2):269–275. doi: 10.1002/eji.1830180214. [DOI] [PubMed] [Google Scholar]
  2. Bourgault I., Gomez A., Gomard E., Picard F., Levy J. P., Gomrad E. A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines. J Immunol. 1989 Jan 1;142(1):252–256. [PubMed] [Google Scholar]
  3. Burrows S. R., Sculley T. B., Misko I. S., Schmidt C., Moss D. J. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J Exp Med. 1990 Jan 1;171(1):345–349. doi: 10.1084/jem.171.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen B. P., Lam V., Kraus E. E., DeMars R., Sondel P. M. Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules. Hum Immunol. 1989 Oct;26(2):137–147. doi: 10.1016/0198-8859(89)90099-2. [DOI] [PubMed] [Google Scholar]
  5. Enssle K. H., Wagner H., Fleischer B. Human mumps virus-specific cytotoxic T lymphocytes: quantitative analysis of HLA restriction. Hum Immunol. 1987 Feb;18(2):135–149. doi: 10.1016/0198-8859(87)90011-5. [DOI] [PubMed] [Google Scholar]
  6. Gomez A., Bourgault I., Gomard E., Picard F., Levy J. P. Role of different lymphocyte subsets in human anti-viral T cell cultures. Cell Immunol. 1989 Feb;118(2):312–327. doi: 10.1016/0008-8749(89)90380-8. [DOI] [PubMed] [Google Scholar]
  7. Gregory C. D., Murray R. J., Edwards C. F., Rickinson A. B. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med. 1988 Jun 1;167(6):1811–1824. doi: 10.1084/jem.167.6.1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Healy F., Sire J., Gomard E., Yssel H., Jordan B., Levy J. P. A study of functionally active amino acids involved in the interaction of HLA-A2 or HLA-A3 molecules with cytolytic T lymphocytes. J Immunol. 1988 Oct 1;141(7):2487–2496. [PubMed] [Google Scholar]
  9. Hengel H., Lindner M., Wagner H., Heeg K. Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses. J Immunol. 1987 Dec 15;139(12):4196–4202. [PubMed] [Google Scholar]
  10. Hickling J. K., Borysiewicz L. K., Sissons J. G. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol. 1987 Nov;61(11):3463–3469. doi: 10.1128/jvi.61.11.3463-3469.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hoffenbach A., Langlade-Demoyen P., Dadaglio G., Vilmer E., Michel F., Mayaud C., Autran B., Plata F. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol. 1989 Jan 15;142(2):452–462. [PubMed] [Google Scholar]
  12. Laux G., Perricaudet M., Farrell P. J. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J. 1988 Mar;7(3):769–774. doi: 10.1002/j.1460-2075.1988.tb02874.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Martinon F., Gomard E., Hannoun C., Lévy J. P. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Eur J Immunol. 1990 Oct;20(10):2171–2176. doi: 10.1002/eji.1830201004. [DOI] [PubMed] [Google Scholar]
  14. Misko I. S., Kane R. G., Pope J. H. Generation in vitro of HLA-restricted EB virus-specific cytotoxic human T cells by autologous lymphoblastoid cell lines: the role of previous EB virus infection and foetal calf serum. Int J Cancer. 1982 Jan 15;29(1):41–48. doi: 10.1002/ijc.2910290108. [DOI] [PubMed] [Google Scholar]
  15. Moss D. J., Misko I. S., Burrows S. R., Burman K., McCarthy R., Sculley T. B. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature. 1988 Feb 25;331(6158):719–721. doi: 10.1038/331719a0. [DOI] [PubMed] [Google Scholar]
  16. Murray R. J., Brooks J. M., Rickinson A. B., Rowe M. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells. Eur J Immunol. 1990 Mar;20(3):659–664. doi: 10.1002/eji.1830200329. [DOI] [PubMed] [Google Scholar]
  17. Murray R. J., Kurilla M. G., Griffin H. M., Brooks J. M., Mackett M., Arrand J. R., Rowe M., Burrows S. R., Moss D. J., Kieff E. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2906–2910. doi: 10.1073/pnas.87.8.2906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Owen J. A., Dudzik K. I., Klein L., Dorer D. R. The kinetics of generation of influenza-specific cytotoxic T-lymphocyte precursor cells. Cell Immunol. 1988 Jan;111(1):247–252. doi: 10.1016/0008-8749(88)90067-6. [DOI] [PubMed] [Google Scholar]
  19. Reiss C. S., Wang D., Ghosh D., Gaposchkin C., Kieff E. Recognition of EBV plasma membrane protein expressed on murine cells after gene transfer. J Immunol. 1987 Aug 1;139(3):711–714. [PubMed] [Google Scholar]
  20. Rickinson A. B., Moss D. J., Wallace L. E., Rowe M., Misko I. S., Epstein M. A., Pope J. H. Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res. 1981 Nov;41(11 Pt 1):4216–4221. [PubMed] [Google Scholar]
  21. Rosenkrantz K., Dupont B., Flomenberg N. Generation and regulation of autocytotoxicity in mixed lymphocyte cultures: evidence for active suppression of autocytotoxic cells. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4508–4512. doi: 10.1073/pnas.82.13.4508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schmid D. S. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex. J Immunol. 1988 May 15;140(10):3610–3616. [PubMed] [Google Scholar]
  23. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981 Apr;126(4):1614–1619. [PubMed] [Google Scholar]
  24. Thorley-Lawson D. A., Israelsohn E. S. Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5384–5388. doi: 10.1073/pnas.84.15.5384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Torsteinsdottir S., Masucci M. G., Brautbar C., Lenoir G., Klein G., Klein E. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Cell Immunol. 1986 Apr 1;98(2):453–466. doi: 10.1016/0008-8749(86)90304-7. [DOI] [PubMed] [Google Scholar]
  26. Torsteinsdottir S., Masucci M. G., Ehlin-Henriksson B., Brautbar C., Ben Bassat H., Klein G., Klein E. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5620–5624. doi: 10.1073/pnas.83.15.5620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Toubert A., Gomard E., Grumet F. C., Amor B., Muller J. Y., Levy J. P. Identification of several functional subgroups of HLA-B27 by restriction of the activity of antiviral T killer lymphocytes. Immunogenetics. 1984;20(5):513–525. doi: 10.1007/BF00364354. [DOI] [PubMed] [Google Scholar]
  28. Wysocka M., Bennink J. R. Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products. Cell Immunol. 1988 Apr 1;112(2):425–429. doi: 10.1016/0008-8749(88)90311-5. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES